Thủy quân lục chiến Indonesia và Mỹ tiến hành tập trận chung

Ngày 13/6, Lực lượng Thủy quân lục chiến Indonesia và Thủy quân lục chiến Mỹ đã bắt đầu cuộc tập trận chung tại khu rừng núi Tumpang Pitu Lampon, Pesanggaran, Banyuwangi Regency, Đông Java, Indonesia, với mật danh Reconex 21-II.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh